Accessibility settings

Published on in Vol 18, No 2 (2016): February

Cialis free trial ad with patient and prescribing information links.

Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis

Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis

Authors of this article:

Crystal Adams1 Author Orcid Image

Journals

  1. Klara K, Kim J, Ross J. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines. Journal of General Internal Medicine 2018;33(5):651 View
  2. Krishna A, Thompson T. Misinformation About Health: A Review of Health Communication and Misinformation Scholarship. American Behavioral Scientist 2021;65(2):316 View
  3. Ju I. The effects of advertising skepticism in consumer prescription drug advertising. International Journal of Pharmaceutical and Healthcare Marketing 2017;11(4):395 View
  4. Aikin K, Sullivan H, Dolina S, Lynch M, Squiers L. Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis. Journal of Medical Internet Research 2017;19(7):e225 View
  5. Ju I. Thinking about fair balance: how prescription drug advertising disclosure prominence works?. International Journal of Pharmaceutical and Healthcare Marketing 2017;11(1):2 View
  6. Giombi K, Thompson J, Wines C, Haughney R, Sullivan H, Betts K. A scoping review of empirical research on prescription drug promotion. Research in Social and Administrative Pharmacy 2023;19(6):859 View
  7. Park S, Hill K, Yun G, Friedman S, Coppes M. Analysis of Direct-To-Consumer Healthcare Service Advertisements on Television: An Application of the Patient Expectation Framework. Health Communication 2023;38(10):2067 View
  8. Flynn M, Lombana-Bermudez A, Palacios A. Latin America’s Digital Media Ecosystem: An Analysis of Prescription Drug Coverage and Diffusion. Journalism and Media 2024;5(4):1786 View
  9. Kravitz R. Health Care Ramifications of Pervasive Direct-to-Consumer Prescription Drug Advertising. Annual Review of Public Health 2026;47(1):479 View
  10. Wang I, Davis C, Forrest R, Cherla A, Siebert M, Cowden J, Walker S, Krishnamurti T, Bourgeois F, Woloshin S, Wagner A, Naci H. Navigating the Prescription Drug Information System. Clinical Pharmacology & Therapeutics 2026 View

Books/Policy Documents

  1. Weisenbach R. Institutionelle Korruption und Arzneimittelvertrieb. View